Clarius Mobile Health has received FDA approval for its Clarius OB AI fetal biometric measurement tool for handheld ultrasound. The tool, developed using deep learning models with over 30,000 fetal ultrasound images, aims to improve access to obstetrical prenatal monitoring in resource-limited areas. It can automatically estimate fetal weight, age, and growth intervals and is available with the Clarius C3 HD3 wireless handheld ultrasound scanner in the US and Canada. The Clarius OB AI provides consistent and precise measurements, allowing new ultrasound users like nurses and midwives to conduct fetal ultrasound exams accurately. The tool highlights key fetal anatomy, places callipers for measurements, and displays them on the screen for easy addition to the patient’s electronic record. Clarius President and CEO Ohad Arazi emphasized the company’s commitment to innovation in the handheld ultrasound market and improving maternal and fetal health outcomes. Earlier this year, Clarius Mobile Health also secured FDA clearance for its Clarius Bladder AI tool, a non-invasive tool for measuring bladder volume, offering real-time feedback to clinicians as a cost-effective alternative to traditional bladder scanners.
Source link
Source link: https://www.medicaldevice-network.com/news/clarius-ob-ultrasound-approval/
Clarius obtains FDA approval for handheld ultrasound AI tool. #MedicalTechnology
Preeti
834 Views
0 Votes
GIPHY App Key not set. Please check settings